A Case of Cytokine Release Syndrome Induced by Avelumab and Axitinib Combination Therapy for Metastatic Renal Cell Carcinoma
This is the first report of CRS associated with avelumab-axitinib therapy in RCC and highlights the importance of early recognition and distinction from IRR, especially when COVID-19 coexists.
Authors
- Hirokazu Kiuchi
- Takahiro Hanai
- Taku Mochizuki
- Kimio Chiba
- Rio Shibata
- Tomoharu Morikawa
- Takashi Kawahara
- Jun‐ichi Teranishi
Institutions
- Fujisawa City Hospital (JP)
- Yokohama City University Medical Center (JP)
- Yokohama City University (JP)
Publication Details
- Journal
- IJU Case Reports
- Published
- 2026-02-13
- DOI
- https://doi.org/10.1002/iju5.70152
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 24.20